$CELG Company News Higher rates are coming —
Post# of 88916
Posted On: 05/15/2014 10:11:47 AM
$CELG Company News
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Hottest Healthcare Stocks Now – HMSY CYH VRTX CELG 1:30 p.m. May 14, 2014 - InvestorPlace.com
Celgene Needs to Clear the Cluster Zone 9:00 a.m. May 14, 2014 - RealMoney.com
Prothena: 4 Different Insiders Have Purchased Shares This Month 11:42 a.m. May 13, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: COP, CELG, BIIB 2:44 p.m. May 12, 2014 - TheStreet.com
Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog 1:00 p.m. May 12, 2014 - Zacks.com
Visualizing Biotech P/E Compression and Why It's a Buy Signal 10:19 a.m. May 12, 2014 - TheStreet.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
UPDATE: Morgan Stanley Reiterates On Celgene Ahead Of Markman Hearing 8:07 a.m. May 12, 2014 - benzinga.com
Investor's Corner: How To Use The Big Cap 20 3:09 p.m. May 8, 2014 - Investors Business Daily
3 Stocks Advancing The Drugs Industry 1:02 p.m. May 8, 2014 - TheStreet.com
RBC Doctor Panel Picks in Drugs and Biotech 7:54 a.m. May 8, 2014 - 247WallSt.com
Fear Not, Biotech Stock 'Correction' Is Not a Bursting Bubble 10:18 a.m. May 7, 2014 - TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You? 10:11 a.m. May 7, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: MU, CAT, CELG 10:59 a.m. May 6, 2014 - TheStreet.com
Celgene: Do The Revlimid Polymorph And Use Patents Matter? 11:44 a.m. May 5, 2014 - Seeking Alpha
Biotech Sector Performance in April: Gilead Sciences Rising 9:49 a.m. May 2, 2014 - TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. May 2, 2014 - TheStreet.com
Merrimack Pancreatic Cancer Treatment Shows Positive Results in Study 4:45 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog 10:55 a.m. April 30, 2014 - Zacks.com
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A 4:26 p.m. April 29, 2014 - TheStreet.com
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014 5:19 p.m. May 14, 2014 - BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes 7:32 a.m. May 7, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes 8:32 a.m. May 6, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver 9:31 a.m. May 1, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders 7:33 a.m. April 24, 2014 - BusinessWire - BZX
Upcoming Earnings Announcements -- Research on Superior Energy Services, Celgene, Penn National Gaming, and PerkinElmer 12:32 p.m. April 22, 2014 - PR Newswire - PRF
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA 8:00 a.m. April 14, 2014 - PR Newswire - PRF
BlackBerry CEO May Consider Exiting Handset Business; Celgene Corporation Favored over Natco in Pre-trial 12:43 a.m. April 10, 2014 - ACCESSWIRE
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading 12:10 a.m. April 7, 2014 - ACCESSWIRE
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:15 p.m. April 4, 2014 - PR Newswire - PRF
Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Critical Alerts For News Corp, Gold SPDR, McDonalds, Trina Solar, and Celgene Released By InvestorsObserver 9:31 a.m. April 1, 2014 - PR Newswire - PRF
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Hottest Healthcare Stocks Now – HMSY CYH VRTX CELG 1:30 p.m. May 14, 2014 - InvestorPlace.com
Celgene Needs to Clear the Cluster Zone 9:00 a.m. May 14, 2014 - RealMoney.com
Prothena: 4 Different Insiders Have Purchased Shares This Month 11:42 a.m. May 13, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: COP, CELG, BIIB 2:44 p.m. May 12, 2014 - TheStreet.com
Will Patterson (PDCO) Disappoint this Earnings Season? - Analyst Blog 1:00 p.m. May 12, 2014 - Zacks.com
Visualizing Biotech P/E Compression and Why It's a Buy Signal 10:19 a.m. May 12, 2014 - TheStreet.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
UPDATE: Morgan Stanley Reiterates On Celgene Ahead Of Markman Hearing 8:07 a.m. May 12, 2014 - benzinga.com
Investor's Corner: How To Use The Big Cap 20 3:09 p.m. May 8, 2014 - Investors Business Daily
3 Stocks Advancing The Drugs Industry 1:02 p.m. May 8, 2014 - TheStreet.com
RBC Doctor Panel Picks in Drugs and Biotech 7:54 a.m. May 8, 2014 - 247WallSt.com
Fear Not, Biotech Stock 'Correction' Is Not a Bursting Bubble 10:18 a.m. May 7, 2014 - TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You? 10:11 a.m. May 7, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: MU, CAT, CELG 10:59 a.m. May 6, 2014 - TheStreet.com
Celgene: Do The Revlimid Polymorph And Use Patents Matter? 11:44 a.m. May 5, 2014 - Seeking Alpha
Biotech Sector Performance in April: Gilead Sciences Rising 9:49 a.m. May 2, 2014 - TheStreet.com
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. May 2, 2014 - TheStreet.com
Merrimack Pancreatic Cancer Treatment Shows Positive Results in Study 4:45 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Biotech Stock Roundup: Gilead's Sovaldi Shines, Biogen & Alexion Up Outlook - Analyst Blog 10:55 a.m. April 30, 2014 - Zacks.com
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A 4:26 p.m. April 29, 2014 - TheStreet.com
Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014 5:19 p.m. May 14, 2014 - BusinessWire - BZX
Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver 9:31 a.m. May 14, 2014 - PR Newswire - PRF
Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene 7:20 a.m. May 13, 2014 - PR Newswire - PRF
Celgene Prices $2.5 Billion of Senior Unsecured Notes 7:32 a.m. May 7, 2014 - BusinessWire - BZX
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Celgene Announces Offering of Senior Unsecured Notes 8:32 a.m. May 6, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene 8:00 a.m. May 5, 2014 - PR Newswire - PRF
New Drug Applications, Quarterly Results, and University Partnerships - Analyst Notes on Celgene, HCA, Thermo Fisher Scientific, Cubist and Agilent 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Critical Alerts For Coca Cola, Baidu.com, Urban Outfitters, Celgene, and Trina Solar Released By InvestorsObserver 9:31 a.m. May 1, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders 7:33 a.m. April 24, 2014 - BusinessWire - BZX
Upcoming Earnings Announcements -- Research on Superior Energy Services, Celgene, Penn National Gaming, and PerkinElmer 12:32 p.m. April 22, 2014 - PR Newswire - PRF
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA 8:00 a.m. April 14, 2014 - PR Newswire - PRF
BlackBerry CEO May Consider Exiting Handset Business; Celgene Corporation Favored over Natco in Pre-trial 12:43 a.m. April 10, 2014 - ACCESSWIRE
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading 12:10 a.m. April 7, 2014 - ACCESSWIRE
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:15 p.m. April 4, 2014 - PR Newswire - PRF
Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Critical Alerts For News Corp, Gold SPDR, McDonalds, Trina Solar, and Celgene Released By InvestorsObserver 9:31 a.m. April 1, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼